Abbott Laboratories logo

Abbott Laboratories (ABT)

Market Open
24 Jun, 09:01
114. 54
-0.6
-0.52%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
0 Volume
4.44 Eps
115.14
Previous Close
Day Range
114.54 115.54
Year Range
90.68 134.2
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 22 days

Summary

ABT trading today lower at €114.54, a decrease of 0.52% from yesterday's close, completing a monthly decrease of -0.19% or €0.22. Over the past 12 months, ABT stock gained 4.55%.
ABT pays dividends to its shareholders, with the most recent payment made on May 15, 2025. The next announced payment will be in In 1 month on Aug 15, 2025 for a total of €0.59.
The last earnings report, released on Apr 15, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 15 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABT Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Best Dividend Kings: June 2025

Best Dividend Kings: June 2025

Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a collective 2025 growth rate of 5.19%, despite some downward earnings revisions. Seventeen Dividend Kings appear undervalued and offer long-term annualized expected returns of at least 10%, based on Dividend Yield Theory analysis.

Seekingalpha | 53 minutes ago
New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier

New Research on Abbott's Healthy Food Rx Program Shows 'Food is Medicine' Approach Helps People Living With Diabetes Eat Better and Feel Healthier

Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows people participating in Abbott's Healthy Food Rx ate more vegetables and fruit, and reported significantly improved health status. Abbott's Healthy Food Rx community-focused "food is medicine" program provides home-delivered healthy food boxes and nutrition education in Stockton, Calif.

Prnewswire | 3 days ago
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 4 days ago

Abbott Laboratories Dividends

Abbott Laboratories logo
ABT In 3 weeks
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 2 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 5 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 8 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 11 months ago
Paid
Quarterly
$0.55 Per Share

Abbott Laboratories Earnings

16 Jul 2025 (In 3 weeks) Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
1.34
Cons. EPS
1.34
EPS
16 Oct 2024 Date
1.2
Cons. EPS
1.21
EPS
18 Jul 2024 Date
1.1
Cons. EPS
1.14
EPS
Abbott Laboratories logo
ABT In 3 weeks
Announced
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 2 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 5 months ago
Paid
Quarterly
$0.59 Per Share
Abbott Laboratories logo
ABT 8 months ago
Paid
Quarterly
$0.55 Per Share
Abbott Laboratories logo
ABT 11 months ago
Paid
Quarterly
$0.55 Per Share
16 Jul 2025 (In 3 weeks) Date
1.25
Cons. EPS
-
EPS
15 Apr 2025 Date
-
Cons. EPS
-
EPS
22 Jan 2025 Date
1.34
Cons. EPS
1.34
EPS
16 Oct 2024 Date
1.2
Cons. EPS
1.21
EPS
18 Jul 2024 Date
1.1
Cons. EPS
1.14
EPS

Abbott Laboratories (ABT) FAQ

What is the stock price today?

The current price is €114.54.

On which exchange is it traded?

Abbott Laboratories is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.25.

When is the next earnings date?

The next earnings report will release on Jul 16, 2025.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

Medical - Devices Industry
Healthcare Sector
Mr. Robert B. Ford CEO
XWBO Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Jul 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100